Wednesday, June 10, 2015

The NIDA has Changed to a Pro-Pot Position

In the last 6 months the National Institute of Drug Abuse has changed their position on medical marijuana. On December 16th, 2014 a report was released by the NIDA that led to their change in opinion. The results showed that acceptance and use of marijuana has gone up dramatically while illicit drugs and alcohol abuse has been reduced.(Source)

In July 2012 NIDA stated:

“The use of marijuana to treat various medical conditions—or “medical marijuana”—is a controversial topic and has been for some time. Some people have argued that marijuana’s reported beneficial effects on a variety of symptoms justify its legalization as a medicine for certain patients. Often the potential harm of marijuana use is not considered in these arguments, although risk is part of what the U.S. Food and Drug Administration (FDA) assesses when deciding whether to approve a medicine.”
A dramatic shift on how NIDA views marijuana was revised in December 2014:
“The marijuana plant contains several chemicals that may prove useful for treating a range of illnesses or symptoms, leading many people to argue that it should be made legally available for medical purposes. In fact, a growing number of states (20 as of March 2014) have legalized marijuana’s use for certain medical conditions.
The term “medical marijuana” is generally used to refer to the whole unprocessed marijuana plant or its crude extracts, which are not recognized or approved as medicine by the U.S. Food and Drug Administration (FDA). But scientific study of the active chemicals in marijuana, called cannabinoids, has led to the development of two FDA-approved medications already, and is leading to the development of new pharmaceuticals that harness the therapeutic benefits of cannabinoids while minimizing or eliminating the harmful side effects (including the “high”) produced by eating or smoking marijuana leaves.”(Source)
This ideology shift has led to recent movements by the government for research and public access to marijuana. On March 10, 2015 the CARERS Act was introduced to downgrade marijuana to a schedule II drug. This bill would remove cannabidiol from the Controlled Substance Act allowing for intrastate sales.

No comments:

Post a Comment